PrEP

Kelly et al., 2024, led by Dr. Nicole Kelly from UC San Diego with co-authors at the University of North Carolina, examines the profound impact of state and local LGBTQ+ policies on HIV prevention among young SGM people, especially Black youth. The study highlights that PrEP (pre-exposure prophylaxis) use among young people significantly increases in regions with protective LGBTQ+ legislation, while discriminatory policies hinder access to life-saving prevention tools

A new CHPRC analysis evaluates the quality of the HIV-related information provided by ChatGPT and other popular chatbots powered by artificial intelligence (AI) and the extent to which these chatbots tailor their responses to address diverse HIV prevention needs.

For 340B-covered entities, core to the challenge of navigating a changing and uncertain policy landscape is the complexity of how multiple variables interact differently with each covered health care entity based on its unique makeup of services, funding, patient population, and payer mix. This toolkit aims to assist 340B covered entities in understanding their current areas of funding stability and where they are vulnerable, and to plan for the future.

In light of proposed and actual changes in Federal and State policy that have the potential to affect the 340B program, we conducted a rapid response study, exploring the impact to facilities that serve people living with or at risk for HIV. As a companion to the Navigating 340B Toolkit, this Explainer takes a closer look at the answers to these three questions: 1. How does 340B work? 2. What is the relationship between 340B and HIV services? 3. What are the current factors impacting 340B revenue for HIV clinical and service organizations?

A new paper published in JAIDS finds that pharmacists could play a key role in providing long-acting injectable pre-exposure prophylaxis (PrEP) for HIV prevention. In a mixed methods analysis of survey and interview data, CHPRC researchers found that many pharmacists would be willing to administer injectable PrEP if provided with training, compensation, and a private room. However, pharmacists may require additional resources and policy support to make widespread implementation feasible.

Policy brief based on a study of seven California emergency departments (ED) implementing HIV Prevention Services (HPS) linkage programs. Three models for integrating HPS into the ED were identified and may serve as a guide for future protocol development.

In February 2024, Senate Bill 339 was signed into law to help realize the goal of widespread access to HIV pre- and post-exposure prophylaxis (PrEP and PEP) in California pharmacies. This fact sheet explains key changes under Senate Bill 339 that may reduce previously-identified barriers to pharmacist delivery of PrEP/PEP.

Paper A Systematic Review of HIV Pre-exposure Prophylaxis (PrEP) Implementation in U.S. Emergency Departments: Patient Screening, Prescribing, and Linkage to Care January 18, 2024 Systematic Review of peer-reviewed quantitative studies and conference abstracts addressing PrEP screening, prescribing, and/or linkage to PrEP care in US Emergency Departments. Further research into the best practices for integrating ED […]

Policy Brief Impact of the Inflation Reduction Act on the 340B Program December 4, 2023 The 340b program provides an important revenue source for many HIV clinics and facilities, but that revenue is dependent on drug pricing. The Inflation Reduction Act of 2022 introduced provisions to curb drug pricing. Our modeling suggests that 340b revenues […]

Infographic Preferences for pharmacist-initiated PrEP implementation in California: Results of a discrete choice experiment October 20, 2023 A new CHPRC analysis reveals California pharmacists’ preferences for implementing pharmacist-initiated PrEP for HIV prevention under Senate Bill 159. In a discrete choice experiment, pharmacists preferred implementation scenarios in which they play an active role in the PrEP […]